Recomendaciones sobre el tratamiento antitrombótico durante la pandemia COVID-19. Posicionamiento del Grupo de Trabajo de Trombosis Cardiovascular de la Sociedad Española de Cardiología

Vivas, David; Roldán, Vanessa; Esteve-Pastor, María Asunción; Roldán, Inmaculada; Tello-Montoliu, Antonio; Ruiz-Nodar, Juan Miguel; Cosín-Sales, Juan; Gámez, José María; Consuegra, Luciano; Ferreiro, José Luis; Marín, Francisco; Arrarte, Vicente; Anguita, Manuel; Cequier, Ángel; Pérez-Villacastín, Julián.
Rev. esp. cardiol. (Ed. impr.) ; 73(9): 749-757, sept. 2020. tab, graf
Artículo en Español | IBECS (España) | ID: ibc-187648

Documentos relacionados

  1. Prothrombin complex concentrate (PCC) for treatment of trauma-induced coagulopathy: systematic review and meta-analyses.
  2. Prevention of Venous Thromboembolism in Medical Patients with Thrombocytopenia or with Platelet Dysfunction: The Last 10 Years.
  3. The Crosstalk between Nephropathy and Coagulation Disorder: Pathogenesis, Treatment, and Dilemmas.
  4. COVID-19-associated coagulopathy in children: A multicenter observational cohort study.
  5. The Year in Coagulation: Selected Highlights From 2019.
  6. A survey on thromboprophylaxis and coagulation assessment in children and young adults with acute lymphoblastic leukaemia (ALL) in the Nordic and Baltic countries: Different practices of assessment and management.
  7. Special Issue "COVID-19 Coagulopathy: Advances on Pathophysiology and Therapies".
  8. Thrombosis, Bleeding, and the Observational Effect of Early Therapeutic Anticoagulation on Survival in Critically Ill Patients With COVID-19.
  9. Anticoagulation in Cancer Patients: a Summary of Pitfalls to Avoid.
  10. Bad weed: synthetic cannabinoid-associated coagulopathy.